Fu, R.; Wang, Y.; Rehman, I.; Bedford, E.; Sharif, S.; Nguyen, N.D.; Powell, R.T.; Adams, A.; Liu, W.; Wang, S.;
et al. Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer. Biomolecules 2026, 16, 1198.
https://doi.org/10.3390/biom16081198
AMA Style
Fu R, Wang Y, Rehman I, Bedford E, Sharif S, Nguyen ND, Powell RT, Adams A, Liu W, Wang S,
et al. Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer. Biomolecules. 2026; 16(8):1198.
https://doi.org/10.3390/biom16081198
Chicago/Turabian Style
Fu, Rongjie, Yalong Wang, Ishita Rehman, Ella Bedford, Sana Sharif, Nghi D. Nguyen, Reid T. Powell, Andrew Adams, Weijun Liu, Shuyue Wang,
and et al. 2026. "Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer" Biomolecules 16, no. 8: 1198.
https://doi.org/10.3390/biom16081198
APA Style
Fu, R., Wang, Y., Rehman, I., Bedford, E., Sharif, S., Nguyen, N. D., Powell, R. T., Adams, A., Liu, W., Wang, S., He, W., Lu, Y., Liu, B., Shah, P. A., Ahnert, J. R., Chen, T., Peng, W., Stephan, C. C., Liu, X.,
... Xu, H.
(2026). Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer. Biomolecules, 16(8), 1198.
https://doi.org/10.3390/biom16081198
